BSX

Boston Scientific Corporation (BSX) Stock Analysis: An Attractive 41% Potential Upside Beckons Investors

January 19, 2026

RTW Biotech Opportunities portfolio company Penumbra to be acquired by Boston Scientific

RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...

January 16, 2026

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 28% Upside Potential for Investors

January 12, 2026

Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors

January 5, 2026

Boston Scientific Corporation (BSX) Investor Outlook: 31% Upside Potential Amid Robust Revenue Growth

December 29, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 31.64% Potential Upside in the Medical Device Sector

December 22, 2025

Boston Scientific Corporation (BSX): Investor Outlook with a 36.62% Upside Potential

December 15, 2025

Boston Scientific Corporation (BSX) Stock Analysis: A 29.7% Potential Upside Opportunity Amid Strong Revenue Growth

December 8, 2025

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 24.52% Upside with Strong Buy Ratings

December 1, 2025

Boston Scientific Corporation (BSX) Investor Outlook: Evaluating a 30% Upside Potential Amidst Strong Buy Ratings

November 24, 2025

Boston Scientific Corporation (BSX) Stock Analysis: 23% Upside Potential and Strong Analyst Support

November 17, 2025

Boston Scientific Corporation (BSX) Investor Outlook: Target Price Suggests 26.46% Upside Potential

November 10, 2025

Boston Scientific Corporation (BSX) Investor Outlook: Analyzing the 25% Potential Upside

November 3, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Impressive 24.75% Potential Upside Captures Investor Attention

October 27, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 25.85% Upside Potential in Medical Devices

October 20, 2025

Boston Scientific Corporation (BSX): Investor Outlook Shows 30.9% Upside Potential with Strong Buy Ratings

October 13, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a Potential 28.49% Upside

October 6, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 26.82% Potential Upside in Medical Devices

September 29, 2025

News and Interview Alerts

Company Presentations

Cerillion Plc Annual KPIs. Substantial Pipeline. Stronger Competitive Position

RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield

Q&As

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video)

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

BrokerTalk

Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP

4 February 2026

Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum

2 February 2026

Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus

28 January 2026

Funds

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Workspace Group PLC (WKP.L) Investor Outlook: What the 14.29% Potential Upside Means for You

6 February 2026

Zigup Plc (ZIG.L) Stock Analysis: Industrial Rental Services Giant with a 30% Upside Potential

6 February 2026

WH Smith PLC (SMWH.L) Investor Outlook: Navigating Potential Upside Amidst Market Challenges

6 February 2026

XPS Pensions Group PLC (XPS.L): Analyst Consensus Points to 29% Upside Potential for UK-Based Pension Specialist

6 February 2026

WORLDWIDE HEALTHCARE TRUST PLC (WWH.L) Stock Analysis: A Look at Recent Price Movements Amidst Strong Buy Ratings

6 February 2026

CNA

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 33% Upside for Healthcare Investors

February 2, 2026

Boston Scientific Corporation (BSX) Stock Analysis: A 34% Potential Upside Amidst Strong Growth

January 26, 2026

Boston Scientific Corporation (BSX) Stock Analysis: An Attractive 41% Potential Upside Beckons Investors

January 19, 2026

RTW Biotech Opportunities portfolio company Penumbra to be acquired by Boston Scientific

RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...